Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy for hypersplenism in malignant lymphomas

P G Gill, R G Souter, P J Morris

    The British Journal of Surgery
    |January 1, 1981
    PubMed
    Summary

    Splenectomy effectively corrects hematological cytopenias in advanced malignant lymphomas, improving treatment continuation and remission rates. This spleen removal surgery offers a safe and valuable option for patients with Hodgkin

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Observation versus late reintroduction of letrozole as adjuvant endocrine therapy for hormone receptor-positive breast cancer (ANZ0501 LATER): an open-label randomised, controlled trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    Within-guild dietary discrimination from 3-D textural analysis of tooth microwear in insectivorous mammals.

    Journal of zoology (London, England : 1987)·2015
    Same author

    Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

    British journal of cancer·2011
    Same author

    Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer.

    Breast (Edinburgh, Scotland)·2006
    Same author

    Sentinel node biopsy in breast cancer--the view from Australia and New Zealand.

    Breast (Edinburgh, Scotland)·2004
    Same author

    Tumour location and prognostic characteristics as determinants of survival of women with invasive breast cancer: South Australian hospital-based cancer registries, 1987-1998.

    Breast (Edinburgh, Scotland)·2004

    Area of Science:

    • Oncology
    • Hematology
    • Surgical Oncology

    Background:

    • Advanced malignant lymphomas often cause hematological cytopenias.
    • These cytopenias can impede or halt essential cancer treatments.
    • Splenic overactivity and reduced bone marrow reserves are common complications.

    Purpose of the Study:

    • To evaluate the efficacy of splenectomy in correcting hematological cytopenias in patients with advanced malignant lymphomas.
    • To assess the impact of splenectomy on treatment continuation and remission rates.
    • To determine the safety and morbidity associated with splenectomy in this patient population.

    Main Methods:

    • Retrospective analysis of 41 patients undergoing splenectomy for advanced malignant lymphomas since 1975.
    • Assessment of hematological correction post-splenectomy.
    • Evaluation of treatment resumption and remission rates after splenectomy.
    • Monitoring of postoperative morbidity and mortality.

    Main Results:

    • Splenectomy achieved a 90% overall rate of hematological correction in both Hodgkin's disease and non-Hodgkin's lymphomas.
    • In patients who resumed chemotherapy post-splenectomy, 87.5% achieved worthwhile remission.
    • No postoperative deaths occurred, and morbidity was acceptably low.

    Conclusions:

    • Splenectomy is a valuable adjunct in managing advanced malignant lymphomas with hematological cytopenias.
    • Consideration of splenectomy is recommended upon signs of splenic overactivity or diminished bone marrow reserves.
    • The procedure demonstrates a favorable safety profile and significant therapeutic benefit.

    Related Experiment Videos